Chad J Roy Selected Research

Aerosols

6/2022	Bioaerosols and airborne transmission: Integrating biological complexity into our perspective.
1/2022	Response to Hypoxia and the Ensuing Dysregulation of Inflammation Impacts Mycobacterium tuberculosis Pathogenicity.
1/2021	Exhaled aerosol increases with COVID-19 infection, age, and obesity.
1/2020	Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions.
1/2020	A New Natural Defense Against Airborne Pathogens.
1/2019	Effective Treatment of Staphylococcal Enterotoxin B Aerosol Intoxication in Rhesus Macaques by Using Two Parenterally Administered High-Affinity Monoclonal Antibodies.
6/2015	Clinical and Pathological Findings Associated with Aerosol Exposure of Macaques to Ricin Toxin.
3/2015	Thermostable ricin vaccine protects rhesus macaques against aerosolized ricin: Epitope-specific neutralizing antibodies correlate with protection.
1/2015	Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine.
1/2014	Evaluation of a Burkholderia pseudomallei Outer Membrane Vesicle Vaccine in Nonhuman Primates.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chad J Roy Research Topics

Disease

24	Infections 12/2022 - 09/2003
18	COVID-19 12/2022 - 01/2020
6	Tuberculosis (Tuberculoses) 01/2022 - 06/2010
4	Melioidosis 05/2014 - 12/2010
4	Smallpox (Variola) 01/2012 - 09/2003
3	Glanders 12/2017 - 03/2005
3	Anthrax 05/2007 - 01/2005
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2019
2	Inflammation (Inflammations) 01/2022 - 01/2012
2	Viremia 09/2020 - 06/2014
2	Edema (Dropsy) 01/2019 - 04/2005
2	Bacterial Infections (Bacterial Infection) 01/2019 - 12/2010
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2015 - 06/2002
2	Fever (Fevers) 06/2015 - 12/2014
2	Septic Shock (Toxic Shock Syndrome) 07/2012 - 06/2002
2	Plague (Bubonic Plague) 01/2006 - 08/2005
2	Shock 04/2005 - 06/2002
1	Hypoxia (Hypoxemia) 01/2022
1	Measles 01/2021
1	Obesity 01/2021
1	Venezuelan Equine Encephalomyelitis 09/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Coronavirus Infections 01/2020
1	Pulmonary Edema 01/2020
1	Orthomyxoviridae Infections 01/2020
1	Bronchiolitis 01/2019
1	Viral Encephalitis 01/2019
1	Primate Diseases 01/2019
1	Equine Encephalomyelitis (Equine Encephalitis) 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Hydrocephalus (Hydrocephaly) 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Arthritis (Polyarthritis) 01/2018
1	Arthralgia (Joint Pain) 01/2018
1	Coinfection 01/2018
1	Poisoning 01/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Dyspnea (Shortness of Breath) 06/2015
1	Tachycardia (Tachyarrhythmias) 06/2015
1	Fibrosis (Cirrhosis) 03/2015
1	Pulmonary Tuberculosis 08/2014
1	Hyperthermia 06/2014
1	Hypothermia 06/2014
1	Sepsis (Septicemia) 05/2014
1	Eastern Equine Encephalomyelitis 03/2013
1	Neuroinflammatory Diseases 01/2013
1	Brucellosis (Malta Fever) 01/2013

Drug/Important Bio-Agent (IBA)

25	VaccinesIBA 01/2022 - 03/2005
22	AerosolsIBA 06/2022 - 09/2003
5	Monoclonal AntibodiesIBA 11/2022 - 07/2012
5	RicinIBA 01/2020 - 01/2012
4	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2021
4	CytokinesIBA 01/2021 - 06/2002
4	Immunoglobulin G (IgG)IBA 12/2017 - 08/2005
4	Biological ProductsIBA 01/2014 - 06/2002
4	Antiviral Agents (Antivirals)IBA 01/2012 - 09/2003
4	AntigensIBA 05/2007 - 08/2005
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2006
3	Pharmaceutical PreparationsIBA 01/2021 - 06/2002
2	Viral RNAIBA 01/2022 - 01/2021
2	ChemokinesIBA 01/2021 - 01/2020
2	Peptides (Polypeptides)IBA 01/2021 - 07/2020
2	acetyl- prolyl- histidyl- seryl- cysteinyl- asparaginamideIBA 01/2021 - 07/2020
2	Neutralizing AntibodiesIBA 01/2021 - 09/2020
2	IntegrinsIBA 01/2021 - 07/2020
2	Attenuated VaccinesIBA 09/2020 - 01/2019
2	PowdersIBA 05/2007 - 01/2005
2	Cidofovir (Vistide)FDA Link 07/2004 - 09/2003
1	FurinIBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	CR3022IBA 01/2021
1	ogalvibartIBA 01/2021
1	NLR ProteinsIBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Histamine Receptors (Histamine Receptor)IBA 01/2021
1	Famotidine (Pepcid)FDA LinkGeneric 01/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	CalciumIBA 01/2020
1	SaltsIBA 01/2020
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2019
1	Bacitracin (Baci-Rx)FDA LinkGeneric 01/2019
1	Virus-Like Particle VaccinesIBA 01/2019
1	Investigational DrugsIBA 01/2019
1	Anti-Infective Agents (Microbicides)IBA 01/2019
1	SolutionsIBA 01/2019
1	Explosive Agents (Explosives)IBA 01/2018
1	Bromodeoxyuridine (BrdU)IBA 01/2018
1	GoldIBA 01/2015
1	GlycoconjugatesIBA 01/2015
1	InterferonsIBA 12/2014
1	salicylhydroxamic acid (SHAM)IBA 06/2014
1	Combined VaccinesIBA 05/2014
1	staphylococcal enterotoxin BIBA 07/2012
1	Gentamicins (Gentamicin)FDA LinkGeneric 02/2012

Therapy/Procedure

7	Therapeutics 01/2022 - 09/2010
1	Euthanasia (Mercy Killing) 01/2022
1	Intranasal Administration 01/2020